Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 30, 2017 - Issue 1
264
Views
11
CrossRef citations to date
0
Altmetric
Case Studies

Dasatinib-Induced Chylothorax in Chronic Myeloid Leukemia

  • Novartis Pharmaceuticals Corporation. Nilotinib prescribing information. East Hanover, NJ: Novartis, 2007. Available at http://www.pharma.us.novartis.com/product/pi/pdf/tasigna.pdf; accessed October 24, 2016.
  • National Cancer Institute. SEER Stat Fact Sheets: Chronic Myeloid Leukemia. Available at http://seer.cancer.gov/statfacts/html/cmyl.html; accessed October 24, 2016.
  • National Comprehensive Cancer Network (NCCN). Chronic Myelogenous Leukemia V.1.2016 [NCCN Clinical Practice Guidelines in Oncology]. Available at http://www.nccn.org/professionals/physician_gls/PDF/cml.pdf; accessed October 24, 2016.
  • Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surg 2007;32 (2): 362–369.
  • Kurekci E, Kaye R, Koehler M. Chylothorax and chylopericardium: a complication of a central venous catheter. J Pediatr 1998;132 (6): 1064–1066.
  • Silen ML, Weber TR. Management of thoracic duct injury associated with fracture-dislocation of the spine following blunt trauma. J Trauma 1995;39 (6): 1185–1187.
  • Worthington MG, de Groot M, Gunning AJ, von Oppell UO. Isolated thoracic duct injury after penetrating chest trauma. Ann Thorac Surg 1995;60 (2): 272–274.
  • Inaty H, Tabba M. A rare case of chylothorax attributed to metastatic prostate carcinoma. J Pulm Respir Med 2013;S14: 002.
  • Brixey AG, Light RW. Pleural eff usions due to dasatinib. Curr Opin Pulm Med 2010;16 (4): 351–356.
  • Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 2003;111 (9): 1287–1295.
  • Hellström M, Kalén M, Lindahl P, Abramsson A, Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 1999;126 (14): 3047–3055.
  • Luton F, Vergés M, Vaerman JP, Sudol M, Mostov KE. The SRC family protein tyrosine kinase p62yes controls polymeric IgA transcytosis in vivo. Mol Cell 1999;4 (4): 627–632.
  • Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997;13 (1): 513–609.
  • Lombardo LJ, Lee FY, Chen P, Norris D, Barrish JC, Behnia K, Castaneda S, Cornelius LA, Das J, Doweyko AM, Fairchild C, Hunt JT, Inigo I, Johnston K, Kamath A, Kan D, Klei H, Marathe P, Pang S, Peterson R, Pitt S, Schieven GL, Schmidt RJ, Tokarski J, Wen ML, Wityak J, Borzilleri RM. Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem 2004;47 (27): 6658–6661.
  • Abram CL, Courtneidge SA. Src family tyrosine kinases and growth factor signaling. Exp Cell Res 2000;254 (1): 1–13.
  • Carragher NO, Westhoff MA, Fincham VJ, Schaller MD, Frame MC. A novel role for FAK as a protease-targeting adaptor protein: regulation by p42 ERK and Src. Curr Biol 2003;13 (16): 1442–1450.
  • Sen B, Johnson FM. Regulation of Src family kinases in human cancers. J Signal Transduct 2011;2011: 865819.
  • McGrath EE, Blades Z, Anderson PB. Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med 2010;104 (1): 1–8.
  • Light RW, Macgregor MI, Luchsinger PC Jr, Ball WC Jr. Pleural eff usions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972;77 (4): 507–513.
  • Agrawal V, Doelken P, Sahn SA. Pleural fluid analysis in chylous pleural effusion. Chest 2008;133 (6): 1436–1441.
  • Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH. Pleural fluid characteristics of chylothorax. Mayo Clin Proc 2009;84 (2): 129–133.
  • Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 1980;55 (11): 700–704.
  • Masiello D, Gorospe G III, Yang AS. The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib. J Hematol Oncol 2009;2 (1): 46.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.